Exascale Labs Holdings Inc. (XLAB) Stock Price & Analysis
Exascale Labs Holdings Inc. (XLAB) closed at USD 1.36 on Thursday, October 15, 2026, up 49.70% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.91; the Oct 15, 2026 session ranged USD 0.78–1.45 on volume of 13,904,908 shares. Market capitalization is $87.50M, with a 52-week range of USD 0.78–11.17 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/XLAB.md
Key facts (XLAB)
- Analysts: None.
- Total return with dividends: 1Y -86.4% vs S&P 500 +18.1%; 5Y -86.3% vs S&P 500 +85.1%.
Analysts (XLAB)
Consensus None.
Total return (dividends reinvested) (XLAB)
| 1Y (from 2025-10-16) | 5Y (from 2025-08-18) | |
|---|---|---|
| Total return | -86.4% | -86.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -86.5% | -82.0% |
| Volatility (annualized) | 95.7% | 102.8% |
| Max drawdown | -91.7% (Jun 2026→Oct 2026) | -91.1% (May 2026→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 1.36 |
|---|---|
| Change | ▲ 49.70% (up) |
| Previous Close | USD 0.91 |
| Open | USD 0.86 |
| Day Range | USD 0.78 – 1.45 |
| 52-Week Range | USD 0.78 – 11.17 |
| Volume | 13,904,908 shares |
| Market Cap | $87.50M |
| Exchange | NGM |
Technical Analysis (XLAB)
Nexqual's technical model rates XLAB "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.72 (oversold) |
| vs SMA50 | Below (USD 3.53) |
| MACD | -0.8 (negative) |
Analyst Ratings (XLAB)
Wall Street analysts rate XLAB "None", per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | None |
|---|
Earnings (XLAB)
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (XLAB)
| Total Revenue | $14.82M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +67.80% |
| Gross Margin | +16.31% |
| Operating Margin | -46.51% |
| Profit Margin | -82.05% |
| Current Ratio | 0.21 |
| Total Cash | $2.69M |
| Total Debt | $0 |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (XLAB)
Nexqual rates Exascale Labs Holdings Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Strong — Revenue +68% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $3M cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (XLAB)
| Insider Ownership | +38.39% |
|---|---|
| Institutional Ownership | +70.11% |
| Shares Outstanding | 33.69M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (XLAB)
Exascale Labs Holdings Inc. is led by Hoansoo Lee (age 41), CEO & Director, per Nexqual as of October 16, 2026 at 05:21 UTC.
| CEO & Director | Hoansoo Lee (age 41) |
|---|---|
| Chief Financial Officer | Jake Carney (age 36) |
| Director of Customer & Investor Relationship | Jonathan Cosino Jaranilla |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PAY | Paymentus Holdings, Inc. | USD 32.13 | ▲ 0.82% |
| TENB | Tenable Holdings, Inc. | USD 39.32 | ▼ 4.77% |
| DLO | DLocal Limited | USD 15.1 | ▲ 0.53% |
| CORZ | Core Scientific, Inc. | USD 14.46 | ▼ 6.32% |
| BLSH | Bullish | USD 31.87 | ▲ 0.31% |
| BB | BlackBerry Limited | USD 8.7 | ▲ 2.72% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt